Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Wells Fargo
WFC
|
$649M |
| 2 |
RTX Corp
RTX
|
$602M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$312M |
| 4 |
Bank of New York Mellon
BK
|
$272M |
| 5 |
Williams Companies
WMB
|
$252M |
Top Sells
| 1 |
FedEx
FDX
|
$2.42B |
| 2 |
Microsoft
MSFT
|
$532M |
| 3 |
Goldman Sachs
GS
|
$470M |
| 4 |
Microchip Technology
MCHP
|
$438M |
| 5 |
Booking.com
BKNG
|
$400M |
Sector Composition
| 1 | Financials | 24.97% |
| 2 | Technology | 18.56% |
| 3 | Healthcare | 15.26% |
| 4 | Communication Services | 15% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Gilead Sciences
GILD
$140B
| $797M | 0.73% | 12,607,853 +15,341 | +0.1% | +$969K |
|
|
HES
52
DELISTED
Hess
HES
| $749M | 0.69% | 18,310,880 -1,943,240 | -10% | -$79.5M |
|
53
Alnylam Pharmaceuticals
ALNY
$58.5B
| $681M | 0.62% | 4,677,613 -26,058 | -0.6% | -$3.79M |
|
54
Baidu
BIDU
$32.8B
| $599M | 0.55% | 4,728,921 -2,074,400 | -30% | -$263M |
|
55
Medtronic
MDT
$119B
| $596M | 0.55% | 5,735,437 -91,749 | -2% | -$9.53M |
|
56
Nutrien
NTR
$28B
| $589M | 0.54% | 15,021,814 +1,209,200 | +9% | +$47.4M |
|
|
57
BioMarin Pharmaceuticals
BMRN
$11.2B
| $587M | 0.54% | 7,720,223 +4,104,483 | +114% | +$312M |
|
58
Otis Worldwide
OTIS
$33.9B
| $550M | 0.5% | 8,818,184 -709,674 | -7% | -$44.3M |
|
59
JD.com
JD
$44.1B
| $517M | 0.47% | 6,664,177 -2,322,000 | -26% | -$180M |
|
60
APA Corp
APA
$8.31B
| $495M | 0.45% | 52,306,246 -1,968,866 | -4% | -$18.6M |
|
|
GAP
61
The Gap, Inc.
GAP
$8.21B
| $455M | 0.42% | 26,731,582 -1,792,799 | -6% | -$30.5M |
|
62
LyondellBasell Industries
LYB
$18.1B
| $451M | 0.41% | 6,398,920 +325,200 | +5% | +$22.9M |
|
|
QVCGA
63
QVC Group, Inc. Series A Common Stock
QVCGA
$69.2M
| $440M | 0.4% | 61,312,174 -1,146,345 | -2% | -$8.23M |
|
64
Televisa
TV
$1.49B
| $418M | 0.38% | 67,557,620 -338,900 | -0.5% | -$2.09M |
|
65
Liberty Global Class C
LBTYK
$4.07B
| $402M | 0.37% | 19,588,661 -8,556,507 | -30% | -$176M |
|
66
Halliburton
HAL
$19.4B
| $378M | 0.35% | 31,372,145 -17,462,861 | -36% | -$210M |
|
67
Linde
LIN
$224B
| $358M | 0.33% | 1,513,390 -1,373,369 | -48% | -$325M |
|
68
Cemex
CX
$13.2B
| $339M | 0.31% | 89,183,590 -16,496,200 | -16% | -$62.7M |
|
69
T-Mobile US
TMUS
$284B
| $329M | 0.3% | 2,878,033 -796,854 | -22% | -$91.1M |
|
70
Aegon
AEG
$12.3B
| $304M | 0.28% | 118,624,517 +2,202,916 | +2% | +$5.64M |
|
71
Ovintiv
OVV
$10.8B
| $296M | 0.27% | 36,262,297 -1,505,500 | -4% | -$12.3M |
|
72
Incyte
INCY
$16.5B
| $295M | 0.27% | 3,288,931 -384,819 | -10% | -$34.5M |
|
73
Fox Class B
FOX
$24.3B
| $287M | 0.26% | 10,278,799 +1,155,029 | +13% | +$32.3M |
|
74
Brighthouse Financial
BHF
$2.7B
| $269M | 0.25% | 9,992,922 -14,861 | -0.1% | -$400K |
|
75
NOV
NOV
$4.94B
| $210M | 0.19% | 23,134,115 -1,728,627 | -7% | -$15.7M |
|